| Cardiovascular responses produced by 5-hydroxytriptamine: a pharmacological update on the receptors/mechanisms involved and therapeutic implications CM Villalón, D Centurión Naunyn-Schmiedeberg's archives of pharmacology 376, 45-63, 2007 | 222 | 2007 |
| Cardiovascular alterations after spinal cord injury: an overview G Bravo, G Guizar-Sahagun, A Ibarra, D Centurión, CM Villalón Current Medicinal Chemistry-Cardiovascular & Hematological Agents 2 (2), 133-148, 2004 | 134 | 2004 |
| An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy CM Villalón, D Centurión, LF Valdivia, P De Vries, PR Saxena PROCEEDINGS-WESTERN PHARMACOLOGY SOCIETY 45, 199-210, 2002 | 85 | 2002 |
| Experimental migraine models and their relevance in migraine therapy U Arulmani, S Gupta, AM VanDenBrink, D Centurión, CM Villalón, ... Cephalalgia 26 (6), 642-659, 2006 | 82 | 2006 |
| Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5‐HT1B/1D receptors and α2‐adrenoceptors CM Villalón, P De Vries, G Rabelo, D Centurión, A Sánchez‐López, ... British journal of pharmacology 126 (3), 585-594, 1999 | 80 | 1999 |
| Mediation of 5‐HT‐induced external carotid vasodilatation in GR 127935‐pretreated vagosympathectomized dogs by the putative 5‐HT7 receptor CM Villalón, D Centurión, M Luján‐Estrada, JA Terrón, A Sánchez‐López British journal of pharmacology 120 (7), 1319-1327, 1997 | 71 | 1997 |
| The suprachiasmatic nucleus is part of a neural feedback circuit adapting blood pressure response FN Buijs, F Cazarez, MC Basualdo, F Scheer, M Perusquía, D Centurion, ... Neuroscience 266, 197-207, 2014 | 65 | 2014 |
| Current and prospective pharmacological targets in relation to antimigraine action S Mehrotra, S Gupta, KY Chan, CM Villalón, D Centurión, PR Saxena, ... Naunyn-Schmiedeberg's archives of pharmacology 378, 371-394, 2008 | 62 | 2008 |
| The canine external carotid vasoconstrictor 5-HT1 receptor: blockade by 5-HT1B (SB224289), but not by 5-HT1D (BRL15572) receptor antagonists P De Vries, A Sánchez-López, D Centurión, JPC Heiligers, PR Saxena, ... European journal of pharmacology 362 (1), 69-72, 1998 | 59 | 1998 |
| 5-HT7, but not 5-HT2B, receptors mediate hypotension in vagosympathectomized rats D Centurión, E Glusa, A Sánchez-López, LF Valdivia, PR Saxena, ... European journal of pharmacology 502 (3), 239-242, 2004 | 58 | 2004 |
| Characterization of putative 5‐HT7 receptors mediating tachycardia in the cat CM Villalón, JPC Heiligers, D Centurión, P De Vries, PR Saxena British journal of pharmacology 121 (6), 1187-1195, 1997 | 56 | 1997 |
| The 5‐HT1‐like receptors mediating inhibition of sympathetic vasopressor outflow in the pithed rat: operational correlation with the 5‐HT1A, 5‐HT1B and 5‐HT1D subtypes CM Villalón, D Centurión, G Rabelo, P de Vries, PR Saxena, ... British journal of pharmacology 124 (5), 1001-1011, 1998 | 47 | 1998 |
| Characterization of the postjunctional α2C‐adrenoceptor mediating vasoconstriction to UK14304 in porcine pulmonary veins T Görnemann, H Von Wenckstern, B Kleuser, CM Villalón, D Centurión, ... British journal of pharmacology 151 (2), 186-194, 2007 | 45 | 2007 |
| Pharmacological profile of the 5‐HT‐induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: Correlation with 5‐HT1 and putative 5‐ht5A/5B receptors A Sánchez‐López, D Centurión, E Vázquez, U Arulmani, PR Saxena, ... British journal of pharmacology 140 (4), 725-735, 2003 | 43 | 2003 |
| Operational characteristics of the 5-HT 1-like receptors mediating external carotid vasoconstriction in vagosympathectomized dogs: close resemblance to the 5-HT 1D receptor subtype CM Villalón, A Sánchez-López, D Centurión Naunyn-Schmiedeberg's archives of pharmacology 354, 550-556, 1996 | 39 | 1996 |
| Further characterization of the 5-HT 1 receptors mediating cardiac sympatho-inhibition in pithed rats: pharmacological correlation with the 5-HT 1B and 5-HT 1D subtypes A Sánchez-López, D Centurión, E Vázquez, U Arulmani, PR Saxena, ... Naunyn-Schmiedeberg's archives of pharmacology 369, 220-227, 2004 | 36 | 2004 |
| The 5-HT1 receptors inhibiting the rat vasodepressor sensory CGRPergic outflow: further involvement of 5-HT1F, but not 5-HT1A or 5-HT1D, subtypes A González-Hernández, G Manrique-Maldonado, J Lozano-Cuenca, ... European journal of pharmacology 659 (2-3), 233-243, 2011 | 35 | 2011 |
| Potential vascular α1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat D Centurión, S Mehotra, A Sánchez-López, S Gupta, ... European journal of pharmacology 535 (1-3), 234-242, 2006 | 34 | 2006 |
| Donitriptan, but not sumatriptan, inhibits capsaicin‐induced canine external carotid vasodilatation via 5‐HT1B rather than 5‐HT1D receptors E Muñoz‐Islas, S Gupta, LR Jiménez‐Mena, J Lozano‐Cuenca, ... British journal of pharmacology 149 (1), 82-91, 2006 | 32 | 2006 |
| 5-Hydroxytryptamine inhibits the tachycardia induced by selective preganglionic sympathetic stimulation in pithed rats CM Villalón, D Centurión, M del Mar Fernández, A Morán, ... Life sciences 64 (20), 1839-1847, 1999 | 32 | 1999 |
Carlos Miguel Villalón HerreraInvestigador Cinvestav 3F, Departamento de Farmacobiología, Cinvestav-IPN, Sede Sur在 cinvestav.mx 的电子邮件经过验证
